Sansure Biotech Inc. (SHA:688289)

Sansure Biotech Statistics

Total Valuation

Sansure Biotech has a market cap or net worth of CNY 10.53 billion. The enterprise value is 7.72 billion.

Market Cap	10.53B
Enterprise Value	7.72B

Important Dates

The next confirmed earnings date is Thursday, April 30, 2026.

Earnings Date	Apr 30, 2026
Ex-Dividend Date	Sep 23, 2025

Share Statistics

Sansure Biotech has 574.18 million shares outstanding. The number of shares has decreased by -0.61% in one year.

Current Share Class	574.18M
Shares Outstanding	574.18M
Shares Change (YoY)	-0.61%
Shares Change (QoQ)	-38.57%
Owned by Insiders (%)	40.06%
Owned by Institutions (%)	10.19%
Float	292.12M

Valuation Ratios

The trailing PE ratio is 53.94 and the forward PE ratio is 26.68.

PE Ratio	53.94
Forward PE	26.68
PS Ratio	6.39
PB Ratio	1.46
P/TBV Ratio	1.80
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	38.95
EV / Sales	4.68
EV / EBITDA	22.50
EV / EBIT	38.12
EV / FCF	n/a

Financial Position

Current Ratio	n/a
Quick Ratio	n/a
Debt / Equity	0.15
Debt / EBITDA	3.21
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is 2.72% and return on invested capital (ROIC) is 4.69%.

Return on Equity (ROE)	2.72%
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	4.69%
Return on Capital Employed (ROCE)	n/a
Weighted Average Cost of Capital (WACC)	7.40%
Revenue Per Employee	702,576
Profits Per Employee	84,463
Employee Count	2,409
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	-22.80M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -24.04% in the last 52 weeks. The beta is 0.71, so Sansure Biotech's price volatility has been lower than the market average.

Beta (5Y)	0.71
52-Week Price Change	-24.04%
50-Day Moving Average	19.62
200-Day Moving Average	20.52
Relative Strength Index (RSI)	33.92
Average Volume (20 Days)	5,452,766

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Sansure Biotech had revenue of CNY 1.65 billion and earned 198.15 million in profits. Earnings per share was 0.34.

Revenue	1.65B
Gross Profit	1.65B
Operating Income	202.43M
Pretax Income	175.35M
Net Income	198.15M
EBITDA	343.06M
EBIT	202.43M
Earnings Per Share (EPS)	0.34

Balance Sheet

The company has 4.01 billion in cash and 1.10 billion in debt, with a net cash position of 2.90 billion or 5.05 per share.

Cash & Cash Equivalents	4.01B
Total Debt	1.10B
Net Cash	2.90B
Net Cash Per Share	5.05
Equity (Book Value)	7.22B
Book Value Per Share	12.42
Working Capital	n/a

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross margin is 100.00%, with operating and profit margins of 12.28% and 12.02%.

Gross Margin	100.00%
Operating Margin	12.28%
Pretax Margin	10.64%
Profit Margin	12.02%
EBITDA Margin	20.81%
EBIT Margin	12.28%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 0.54, which amounts to a dividend yield of 2.93%.

Dividend Per Share	0.54
Dividend Yield	2.93%
Dividend Growth (YoY)	19.33%
Years of Dividend Growth	1
Payout Ratio	n/a
Buyback Yield	0.61%
Shareholder Yield	3.58%
Earnings Yield	1.88%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on June 1, 2022. It was a forward split with a ratio of 1.48.

Last Split Date	Jun 1, 2022
Split Type	Forward
Split Ratio	1.48

Scores

Altman Z-Score	n/a
Piotroski F-Score	2